SCHEMBL2418933

SCHEMBL2418933

CCCCCCCCCCCCCCC(CC(=O)O)(C(=O)O)S(=O)(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.41
FFAR1 O14842 2/20 0.41
CPT2 P23786 1/20 0.41
HSPD1 P10809 1/20 0.41
BLM P54132 1/20 0.41
HSPE1 P61604 1/20 0.41
GPR84 Q9NQS5 7/20 0.39
PPARG P37231 7/20 0.39
PPARD Q03181 7/20 0.39
PPARA Q07869 7/20 0.39
HDAC11 Q96DB2 5/20 0.39
TSHR P16473 4/20 0.39
PTPN1 P18031 3/20 0.39
ALDH1A1 P00352 2/20 0.39
TLR2 O60603 2/20 0.39
FABP4 P15090 2/20 0.39
SLC22A6 Q4U2R8 1/20 0.39
SLC22A8 Q8TCC7 1/20 0.39
MEN1 O00255 1/20 0.39
ESR1 P03372 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28189670 1.00 TDP1 (0.41) TDP1FFAR1CPT2HSPD1BLM
SCHEMBL749698 1.00 TDP1 (0.41) TDP1FFAR1CPT2HSPD1BLM
SCHEMBL573838 1.00 TDP1 (0.41) TDP1FFAR1CPT2HSPD1BLM
SCHEMBL208623 1.00 TDP1 (0.41) TDP1FFAR1CPT2HSPD1BLM
Tridecane SCHEMBL11754456 1.00 TDP1 (0.41) TDP1FFAR1CPT2HSPD1BLM
SCHEMBL1840384 1.00 TDP1 (0.41) TDP1FFAR1CPT2HSPD1BLM
SCHEMBL9836853 1.00 TDP1 (0.41) TDP1FFAR1CPT2HSPD1BLM
SCHEMBL9645095 1.00 TDP1 (0.41) TDP1FFAR1CPT2HSPD1BLM
SCHEMBL2314036 1.00 TDP1 (0.41) TDP1FFAR1CPT2HSPD1BLM
SCHEMBL28135836 1.00 TDP1 (0.41) TDP1FFAR1CPT2HSPD1BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112521518-B Modified starch and preparation method and application thereof 瑞辰星生物技术(广州)有限公司 2023-04-07 CN disclosed
CN-112520831-B Method for recovering free starch in papermaking white water 瑞辰星生物技术(广州)有限公司 2023-03-14 CN disclosed
CN-112522989-B Method for making paper 瑞辰星生物技术(广州)有限公司 2022-07-29 CN disclosed
CN-112522989-A Method for making paper 瑞辰星生物技术(广州)有限公司 2021-03-19 CN disclosed
CN-112521518-A Modified starch and preparation method and application thereof 瑞辰星生物技术(广州)有限公司 2021-03-19 CN disclosed
CN-112520831-A Method for recovering free starch in papermaking white water 瑞辰星生物技术(广州)有限公司 2021-03-19 CN disclosed
US-20180163056-A1 HYDROPHILIC CURABLE COMPOSITIONS MITSUI CHEMICALS, INC. (JP) 2018-06-14 US disclosed
EP-3006013-B1 ORAL COMPOSITION CONTAINING DIAMOND PARTICLES SUNSTAR SUISSE SA (CH) 2018-05-30 EP disclosed
EP-3081578-A1 COMPOSITION FOR HYDROPHILIC CURED PRODUCT Mitsui Chemicals, Inc. (JP) 2016-10-19 EP disclosed
US-20160120774-A1 ORAL COMPOSITION CONTAINING DIAMOND PARTICLES SUNSTAR SUISSE SA (CH) 2016-05-05 US disclosed
EP-3006013-A1 ORAL COMPOSITION CONTAINING DIAMOND PARTICLES Sunstar Suisse SA (CH) 2016-04-13 EP disclosed
CN-105307623-A Oral composition containing diamond particles SUNSTAR SUISSE SA 2016-02-03 CN disclosed
CN-104274334-A Composition for cleaning SUZHOU YUANSUJI CHEMICAL INDUSTRY CO LTD 2015-01-14 CN disclosed
CN-104274340-A Composition with stable liquid crystal structure and application of composition SUZHOU YUANSUJI CHEMICAL INDUSTRY CO LTD 2015-01-14 CN disclosed
EP-1410789-B1 ORAL PREPARATION SUNSTAR INC (JP) 2011-09-21 EP disclosed
US-7166272-B2 Oral preparation SUNSTAR INC. (JP) 2007-01-23 US disclosed
US-20040146465-A1 Oral preparation SUNSTAR INC. (JP) 2004-07-29 US disclosed
EP-1410789-A1 ORAL PREPARATION Sunstar Inc. (JP) 2004-04-21 EP disclosed
US-4130640-A IODOPHOR, SULFATE OR SULFOSUCCINATE OF FATTY ALCOHOL CHAZAN REUWEN R 1978-12-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040146465-A1 Oral preparation MSR1, OLA1, OR10J3 TDP1 2510/4885FFAR1 343/4885CPT2 3806/4885
US-20160120774-A1 ORAL COMPOSITION CONTAINING DIAMOND PARTICLES RPP30, DHX30, CD68 TDP1 1295/4885FFAR1 2506/4885CPT2 4671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.